Showing results (81-90 of 111) with videos related to
Sort By:
Pageof 12
Molecular Cancer Therapeutics|March 5, 2022
A Preclinical Study to Repurpose Spironolactone for Enhancing Chemotherapy Response in Bladder CancerDongbo Xu, Qiang Cao, Li Wang, et al.Journal of the National Cancer Institute|October 10, 2014
The Thoc1 ribonucleoprotein and prostate cancer progressionMeenalakshmi Chinnam, Yanqing Wang, Xiaojing Zhang, et al.Cancers|May 28, 2022
Single-Cell Analyses of a Novel Mouse Urothelial Carcinoma Model Reveal a Role of Tumor-Associated Macrophages in Response to Anti-PD-1 TherapyDongbo Xu, Li Wang, Kyle Wieczorek, et al.Journal of Neurology|April 7, 2024
Progression to corticobasal syndrome: a longitudinal study of patients with nonfluent primary progressive aphasia and primary progressive apraxia of speechDanna P Garcia-Guaqueta, Hugo Botha, Rene L Utianski, et al.The Journal of Clinical Investigation|June 2, 2022
A mitochondrial unfolded protein response inhibitor suppresses prostate cancer growth in mice via HSP60Rahul Kumar, Ajay K Chaudhary, Jordan Woytash, et al.Cancer Research|November 12, 2025
EZH2 Suppression Diversifies Prostate Cancer Lineage Variant Evolution and Lacks Efficacy in Inhibiting Disease ProgressionJustine J Jacobi, Kristine M Wadosky, Neha Jaiswal, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 20, 2025
Relationships between hypometabolism and both β-amyloid and tau PET in corticobasal syndromeAlma Ghirelli, Austin W Goodrich, Yehkyoung C Stephens, et al.Oral Oncology|January 24, 2026
Prognostic associations of systemic inflammation response index (SIRI) in patients with head and neck cancer: a systematic review and meta-analysisNeil D Almeida, Tyler V Schrand, Daniel Sullivan, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 8, 2006
Clinical efficacy of lenalidomide in patients with relapsed or refractory chronic lymphocytic leukemia: results of a phase II studyAsher Chanan-Khan, Kena C Miller, Laurie Musial, et al.Molecular Cell|December 12, 2018
Phosphorylated RB Promotes Cancer Immunity by Inhibiting NF-κB Activation and PD-L1 ExpressionXin Jin, Donglin Ding, Yuqian Yan, et al.Pageof 12